These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11923640)

  • 1. Identifying tumor vascular permeability heterogeneity with magnetic resonance imaging contrast agents.
    Aref M; Brechbiel M; Wiener EC
    Invest Radiol; 2002 Apr; 37(4):178-92. PubMed ID: 11923640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
    Daldrup H; Shames DM; Wendland M; Okuhata Y; Link TM; Rosenau W; Lu Y; Brasch RC
    AJR Am J Roentgenol; 1998 Oct; 171(4):941-9. PubMed ID: 9762973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
    Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
    Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
    Daldrup H; Shames DM; Wendland M; Okuhata Y; Link TM; Rosenau W; Lu Y; Brasch RC
    Pediatr Radiol; 1998 Feb; 28(2):67-78. PubMed ID: 9472047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macromolecular contrast media-enhanced MRI estimates of microvascular permeability correlate with histopathologic tumor grade.
    Brasch RC; Daldrup H; Shames D; Wendland M; Okuhata Y; Rosenau W
    Acad Radiol; 1998 Apr; 5 Suppl 1():S2-5. PubMed ID: 9561030
    [No Abstract]   [Full Text] [Related]  

  • 6. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation.
    Turetschek K; Huber S; Floyd E; Helbich T; Roberts TP; Shames DM; Tarlo KS; Wendland MF; Brasch RC
    Radiology; 2001 Feb; 218(2):562-9. PubMed ID: 11161179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy.
    Feng Y; Emerson L; Jeong EK; Parker DL; Lu ZR
    J Magn Reson Imaging; 2009 Aug; 30(2):401-6. PubMed ID: 19629979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow versus permeability weighting in estimating the forward volumetric transfer constant (K
    Li CH; Chen FH; Schellingerhout D; Lin YS; Hong JH; Liu HL
    Magn Reson Imaging; 2017 Feb; 36():105-111. PubMed ID: 27989901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging.
    Daldrup-Link HE; Shames DM; Wendland M; Mühler A; Gossmann A; Rosenau W; Brasch RC
    Acad Radiol; 2000 Nov; 7(11):934-44. PubMed ID: 11089696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy.
    Schwickert HC; Stiskal M; Roberts TP; van Dijke CF; Mann J; Mühler A; Shames DM; Demsar F; Disston A; Brasch RC
    Radiology; 1996 Mar; 198(3):893-8. PubMed ID: 8628889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation.
    Cohen FM; Kuwatsuru R; Shames DM; Neuder M; Mann JS; Vexler V; Rosenau W; Brasch RC
    Invest Radiol; 1994 Nov; 29(11):970-7. PubMed ID: 7890512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of the extraction fraction for gadopentetate across breast cancer capillaries.
    Daldrup HE; Shames DM; Husseini W; Wendland MF; Okuhata Y; Brasch RC
    Magn Reson Med; 1998 Oct; 40(4):537-43. PubMed ID: 9771570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution.
    Demsar F; Roberts TP; Schwickert HC; Shames DM; van Dijke CF; Mann JS; Saeed M; Brasch RC
    Magn Reson Med; 1997 Feb; 37(2):236-42. PubMed ID: 9001148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density.
    van Dijke CF; Brasch RC; Roberts TP; Weidner N; Mathur A; Shames DM; Mann JS; Demsar F; Lang P; Schwickert HC
    Radiology; 1996 Mar; 198(3):813-8. PubMed ID: 8628876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
    Cheng HL; Wallis C; Shou Z; Farhat WA
    J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology.
    Turetschek K; Floyd E; Helbich T; Roberts TP; Shames DM; Wendland MF; Carter WO; Brasch RC
    J Magn Reson Imaging; 2001 Sep; 14(3):237-42. PubMed ID: 11536400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium-free extracellular MR contrast agent for tumor imaging.
    Nofiele JT; Haedicke IE; Zhu Yle K; Zhang XA; Cheng HL
    J Magn Reson Imaging; 2015 Feb; 41(2):397-403. PubMed ID: 24399613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).
    Cyran CC; Sennino B; Fu Y; Rogut V; Shames DM; Chaopathomkul B; Wendland MF; McDonald DM; Brasch RC; Raatschen HJ
    Eur J Radiol; 2012 May; 81(5):891-6. PubMed ID: 21889860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas.
    Brasch RC; Shames DM; Cohen FM; Kuwatsuru R; Neuder M; Mann JS; Vexler V; Mühler A; Rosenau W
    Invest Radiol; 1994 Jun; 29 Suppl 2():S8-11. PubMed ID: 7928277
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology.
    Turetschek K; Floyd E; Shames DM; Roberts TP; Preda A; Novikov V; Corot C; Carter WO; Brasch RC
    Magn Reson Med; 2001 May; 45(5):880-6. PubMed ID: 11323815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.